A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept
Clinical trial NCT07075406 · COMPLETED
Trial details
- NCT number
- NCT07075406
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-08-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.